DSKYF Projected Dividend Yield
Ord/Daiichi Sankyo Co Ltd ( OTCBB : DSKYF )Daiichi Sankyo is mainly engaged in the research, development, manufacture, sale and marketing of pharmaceutical products. Co. offers prescription drugs, including "ENHERTU" for cancer treatments, anticoagulants "LIXIANA/SAVAYSA," antihypertensive agents "MINNEBRO," antipatelet agents "EFFIENT," "CANALLIA" for type 2 diabetes mellitus, "Injectafer" for iron deficiency anemia and "NEXIUM" for ulcers treatments, as well as influenza vaccines, measles/rubella vaccines and mumps vaccines. Co also manufactures over-the-counter drugs, cosmetics and medical equipment. Co. operates its business activities in Japan, the Americas, Europe, China and Asia. 26 YEAR PERFORMANCE RESULTS |
DSKYF Dividend History Detail DSKYF Dividend News DSKYF Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend Amount (JPY) |
2024 |
N/A |
N/A |
Sep 30, 2024 |
Dec 10, 2024 |
30.0000 |
2024 |
N/A |
N/A |
Mar 31, 2024 |
Jun 18, 2024 |
30.0000 |
2024 Total: |
60.0000 |
||||
2023 |
N/A |
N/A |
Sep 30, 2023 |
Dec 08, 2023 |
20.0000 |
2023 |
N/A |
N/A |
Mar 31, 2023 |
Jun 20, 2023 |
15.0000 |
2023 Total: |
35.0000 |
||||
2022 |
N/A |
N/A |
Sep 30, 2022 |
Dec 01, 2022 |
15.0000 |
2022 |
N/A |
N/A |
Mar 31, 2022 |
Jun 28, 2022 |
13.5000 |
2022 Total: |
28.5000 |
||||
2021 |
N/A |
N/A |
Sep 30, 2021 |
Dec 01, 2021 |
13.5000 |
2021 |
N/A |
N/A |
Mar 31, 2021 |
Jun 22, 2021 |
13.5000 |
2021 Total: |
27.0000 |
||||
2020 |
N/A |
N/A |
Sep 30, 2020 |
Dec 01, 2020 |
13.5000 |
2020 |
N/A |
N/A |
Mar 31, 2020 |
Jun 16, 2020 |
11.6667 |
2020 Total: |
25.1667 |